These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8094282)

  • 1. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
    Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
    Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer.
    Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
    Cancer; 1992 Jun; 69(12):2953-60. PubMed ID: 1350504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between lymph node metastases and DNA-ploidy status as prognostic factors in invasive breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Surg Today; 1992; 22(3):213-20. PubMed ID: 1392324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.
    Noguchi M; Taniya T; Ohta N; Koyasaki N; Miyazaki I; Mizukami Y
    Breast Cancer Res Treat; 1991 Sep; 19(1):23-31. PubMed ID: 1661623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of internal mammary lymph node metastases in breast cancer patients].
    Noguchi M; Ota N; Koyazaki N; Taniya T; Miyazaki I; Mizukami Y
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):295-9. PubMed ID: 1513310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patients.
    Noguchi M; Ohta N; Thomas M; Kitagawa H; Miyazaki I
    J Surg Oncol; 1993 Jan; 52(1):26-30. PubMed ID: 8441257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
    Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
    Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
    Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
    Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
    Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
    J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study on the clinical and biological prediction of axillary lymph node metastasis in breast cancer.
    Noguchi M; Ohta N; Thomas M; Kitagawa H; Earashi M; Miyazaki I; Mizukami Y
    Surg Today; 1993; 23(7):573-9. PubMed ID: 8103689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive parameters for internal mammary node drainage in patients with early breast cancer.
    Lukesova L; Vrana D; Gatek J; Koranda P; Cwiertka K; Radova L; Melichar B; Prouzova Z; Sramek V; Svach I
    Tumori; 2014; 100(3):254-8. PubMed ID: 25076234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival.
    Yuan J; Hennessy C; Corbett IP; Dykin R; Givan AL; Shenton BK; Henry JA; Wright C; Lennard TW
    Br J Surg; 1991 Jul; 78(7):844-8. PubMed ID: 1678669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is c-erb B-2 a predictor for recurrent disease in early stage breast cancer?
    Pierce LJ; Merino MJ; D'Angelo T; Barker EA; Gilbert L; Cowan KH; Steinberg SM; Glatstein E
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):395-403. PubMed ID: 7903962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes.
    Mittra I; Redkar AA; Badwe RA
    J Surg Oncol; 1995 Oct; 60(2):106-11. PubMed ID: 7564375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up.
    Toikkanen S; Helin H; Isola J; Joensuu H
    J Clin Oncol; 1992 Jul; 10(7):1044-8. PubMed ID: 1351537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
    Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
    Prasad AR; Divine G; Zarbo RJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.